HCSG · Insider Trading

Healthcare Services Group

Every open-market purchase and sale reported by HCSG officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
50
most recent
Open-Market Buys
0
code P
Sales
3
code S
Reporting Insiders
17
current holders
HCSG — Recent Form 4 Transactions (latest 2026-10-01)
FiledInsiderRole TypeSharesValue
2026-10-01 Thomas Gerard Whalen Director A +123 +$2.52K
2026-10-01 Laura K Grant Director A +367 +$7.51K
2026-10-01 Kurt Simmons JR Director A +734 +$15.01K
2026-08-05 Andrew Kush EVP & Chief Operating Officer Sell −15,598 −$362.50K
2026-07-02 Thomas Gerard Whalen Director A +102 +$2.51K
2026-07-02 Laura K Grant Director A +306 +$7.52K
2026-07-02 Andrew M Brophy SVP & Chief Accounting Officer A +4,381 —
2026-07-02 Kurt Simmons JR Director A +611 +$15.01K
2026-05-29 Vikas Singh EVP & Chief Financial Officer MIXED +1,267 —
2026-05-28 Daniela Castagnino Director A +1,969 +$40.01K
2026-05-28 Thomas Gerard Whalen Director A +1,969 +$40.01K
2026-05-28 Diane S Casey Director A +1,969 +$40.01K
2026-05-28 Dino D Ottaviano Director A +1,969 +$40.01K
2026-05-28 Thomas Michael Gallagher Director A +1,969 +$40.01K
2026-05-28 Jude Visconto Director A +1,969 +$40.01K
2026-05-28 Laura K Grant Director A +1,969 +$40.01K
2026-05-28 Vikas Singh EVP & Chief Financial Officer MIXED +1,267 deriv. —
2026-05-28 Kurt Simmons JR Director A +1,969 +$40.01K
2026-04-02 Kurt Simmons JR Director A +809 +$15.01K
2026-04-02 Laura K Grant Director A +405 +$7.51K
2026-04-02 Thomas Gerard Whalen Director A +135 +$2.50K
2026-02-26 Andrew M Brophy SVP & Chief Accounting Officer MIXED −2,729 −$59.27K
2026-02-26 Theodore WAHL President & CEO MIXED +49,396 −$778.81K
2026-02-26 John Christopher Shea EVP & Chief Admin. Officer MIXED +9,807 −$154.66K
2026-02-26 Patrick J Orr EVP & Chief Revenue Officer MIXED +7,417 −$116.97K
2026-02-26 Jason J Bundick EVP/Gen. Counsel/Corp. Secty. MIXED +7,494 −$118.19K
2026-02-26 Andrew Kush EVP & Chief Operating Officer MIXED +9,807 −$154.66K
2026-02-20 Patrick J Orr EVP & Chief Revenue Officer Sell −44,615 −$915.83K
2026-02-19 John Christopher Shea EVP & Chief Admin. Officer MIXED −15,500 −$446.51K
2026-02-19 Theodore WAHL President & CEO MIXED — —
2026-02-19 Patrick J Orr EVP & Chief Revenue Officer MIXED — −$269.23K
2026-01-06 John Christopher Shea EVP & Chief Admin. Officer MIXED +11,816 +$21.19K
2026-01-06 Theodore WAHL President & CEO MIXED +51,496 +$21.19K
2026-01-06 Jason J Bundick EVP/Gen. Counsel/Corp. Secty. MIXED +7,361 —
2026-01-06 Patrick J Orr EVP & Chief Revenue Officer MIXED +10,527 +$21.19K
2026-01-06 Vikas Singh EVP & Chief Financial Officer MIXED +2,080 —
2026-01-06 Andrew Kush EVP & Chief Operating Officer MIXED +9,673 —
2026-01-06 Andrew M Brophy SVP & Chief Accounting Officer MIXED +5,846 —
2026-01-05 Kurt Simmons JR Director A +785 +$15.01K
2026-01-05 Thomas Gerard Whalen Director A +131 +$2.50K
2025-10-29 Andrew Kush EVP & Chief Operating Officer D −28,612 −$547.35K
2025-10-29 Jason J Bundick EVP/Gen. Counsel/Corp. Secty. D −20,996 −$399.76K
2025-10-02 Thomas Gerard Whalen Director A +149 +$2.51K
2025-10-02 Kurt Simmons JR Director A +892 +$15.01K
2025-07-30 John Christopher Shea EVP & Chief Admin. Officer Sell −21,368 −$283.13K
2025-07-02 Kurt Simmons JR Director A +999 +$15.01K
2025-07-02 Thomas Gerard Whalen Director A +65 +$977
2025-06-04 Thomas Gerard Whalen Director A +2,806 +$40.01K
2025-05-29 John J McFadden JR Director A +2,806 +$40.01K
2025-05-29 Vikas Singh EVP & Chief Financial Officer A +11,010 deriv. —
HCSG — Current Insider Holders
InsiderRole Shares HeldValue
Theodore WAHL President & CEO 641,176 $16.11M
John Christopher Shea EVP & Chief Admin. Officer 39,099 $982.17K
Kurt Simmons JR Director 31,504 $791.38K
Jason J Bundick EVP/Gen. Counsel/Corp. Secty. 29,812 $748.88K
Robert L Frome Director 27,066 $679.90K
Andrew Kush EVP & Chief Operating Officer 22,741 $571.25K
Andrew M Brophy SVP & Chief Accounting Officer 19,922 $500.44K
Laura K Grant Director 18,681 $469.27K
Dino D Ottaviano Director 15,409 $387.07K
Daniela Castagnino Director 14,975 $376.17K
Jude Visconto Director 14,975 $376.17K
Diane S Casey Director 14,975 $376.17K
John J McFadden JR Director 13,006 $326.71K
Patrick J Orr EVP & Chief Revenue Officer 7,417 $186.32K
Thomas Gerard Whalen Director 5,480 $137.66K
Vikas Singh EVP & Chief Financial Officer 4,282 $107.56K
Thomas Michael Gallagher Director 1,969 $49.46K
HCSG Insider Trading FAQ
Who are the insiders at HCSG?
17 officers, directors and 10%+ beneficial owners currently report holdings in HCSG via SEC Form 4.
Are HCSG insiders buying or selling?
Across the 50 most recent Form 4 filings for HCSG, 0 were open-market purchases (code P) and 3 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is HCSG insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent HCSG filing is dated 2026-10-01.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the HCSG quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.